Trimetazidine and Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy

This randomized clinical trial at a tertiary referral center in the United Kingdom compares the effects of oral trimetazidine hydrochloride vs placebo on exercise capacity among patients with nonobstructive hypertrophic cardiomyopathy.

Read the full article here

Related Articles